DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Market Research Report by Diseases, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmology Marke…
Author: Business Wire
Europe Eyewear and Optical Retailers Database 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear and Optical Retailers in Europe” newsletter has been added to ResearchAndMarkets.com’s offering. For each country, similar rankings are provided covering all the major optical retailers. This database covers all ma…
Insights on the Ophthalmic Equipment Global Market to 2027 – Featuring Alcon, Canon Medical Systems and Diamatrix Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Equipment Market Research Report by Product, by End-user, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmic Eq…
Worldwide Corneal Topographers Industry to 2027 – Increasing Number of LASIK Surgeries Across the World is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Topographers Market Research Report by Product, by Application, by End-user, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Glob…
Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CSTL–Castle announced the publication of a study in Ocular Oncology and Pathology related to the Company’s DecisionDx®-UMSeq 7-gene DNA sequencing panel.
Global Posterior Segment Eye Disorders Market (2020 to 2025) – Growth, Trends and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Posterior Segment Eye Disorders Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The global posterior segment eye disorders market is projected to grow with a…
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Eye Health America Enters Georgia with a Leading Group, Southeast Retina Center, Based in Augusta, Georgia
GREENVILLE, S.C.–(BUSINESS WIRE)–Southeast Retina Center (SERC), led by Dennis Marcus, MD, welcomed the New Year last week by joining Eye Health America (EHA) on December 31st, 2021. Dr. Marcus, with 27 years of experience, is well-respected and reco…
The Worldwide AR Glasses Industry is Expected to Reach $883.4 Million by 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “AR Glasses Market – Global Industry Analysis (2017 – 2020) – Growth Trends and Market Forecast (2021 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The global AR glasses market will be valued at $883….
UnitedHealthcare Enhances Eye Care Program by Helping Reduce People’s Exposure to Blue Light
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is investing in new ways to help children and adults across the country reduce their exposure to blue light and support their overall eye health, amid ongoi…
Aldeyra Therapeutics Announces Positive Top-Line Data from Phase 2 Dry Eye Chamber Clinical Trial of Reproxalap, an Investigational New Drug, Compared to Xiidra®
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced positive top-line data from a…
Worldwide Prescription Lens Industry to 2027 – Increasing Living Standards Among Young Population with the Need for Trending Sunglasses and Lens Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Prescription Lens Market Research Report by Type, by Application, by Coating, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The global pres…
Worldwide Advanced Ophthalmology Technologies Industry to 2027 – Technological Advancements in Ophthalmic Devices Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Advanced Ophthalmology Technologies Market Research Report by Type, by End-user, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The global a…
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
GENEVA–(BUSINESS WIRE)–Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
Gemini Therapeutics Provides GEM103 Program Update
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration (AMD), today announced updates from its o…
NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals launches Avenova Lubricating Eye Drops for the immediate relief of dry eye symptoms.
Harrow Health to Participate in H.C. Wainwright BioConnect Conference
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the H.C…
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
GENEVA–(BUSINESS WIRE)–Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio